# Charité Berlin

CRISPR Meets Nanoparticles: A New Path to Repair Human Skin

A Canada–Germany team has developed a CRISPR gene‑editing therapy delivered by nanoparticles designed for direct use on human skin, published in Cell Stem Cell. The approach promises localized correction of pathogenic mutations and could reshape treatment prospects for genetic skin diseases, though safety and durability must be proven in clinical testing.